Compared with the control group, the percentage of IFN-γ+ CD4+ or IFN-γ+ CD8+ T cells was significantly increased in tumor after treatment with either OX40 antibody, and the level of increase was similar between these two antibodies (Figures 5C). Here, TNFRSF4 is linked to neoplasm.